top of page
D41DD146-4A53-441A-8033-D8BE877D5FAE_edited.jpg
726C19B0-9FA9-4329-BCAE-984DDD1BC3EE.jpeg

Working to Uncover TNBC

No matter what type of cancer you have, you're in for a fight. But for Black women who have a higher chance of developing or are newly diagnosed with triple-negative breast cancer (TNBC), it can be an uphill battle. Not only are non-Hispanic Black women ~2x more likely to have TNBC than non-Hispanic white women, they also face barriers like delays between diagnosis and treatment and lack of adequate insurance or resources.

Our Founder, sharing her TNBC journey as a Merck Uncover TNBC Hometown Hero.

What is Triple Negative Breast Cancer (TNBC)

TNBC (triple-negative breast cancer) does not have 3 receptors (proteins) that help other breast cancers grow: estrogen receptors, progesterone receptors or extra HER2 receptors. This makes it "triple-negative."

​

​Something else is helping the cancer to grow. This means treatments that are commonly used for types of breast cancer that have those receptors may not work to treat TNBC.

Learn More About Triple Negative Breast Cancer

bottom of page